Mid-term syllabus of Biochem-510: Introduction to industrial management; Basic functions of management; Forms of business and organizational structure; Introduction to manufacturing; Introduction to industrial marketing; Understanding of financial management; Human resource management practices; Basics of operations and productivity; Purchasing and inventory control; Basics of plant layout; Industrial safety and risk management; Lean production; Industrial scheduling; Forecasting methods; Understanding of supply chain dynamics; Industrial operations and leadership
…. PLUS…. First 150 MCQs from chapters 2 of the book ” MCQs in Biochemistry”. MCQs from the taught concepts and book chapters will also appear in the exam.
Final syllabus of Biochem-510:Overview of quality and quality control systems, Comparison between quality control and quality assurance, The ISO 9000 standard for quality management systems, Sector-specific standards, ISO 9001 requirements, ISO 14000 series standards, Failure mode and effect analysis, Total productive maintenance, Managing quality improvement teams and projects, Statistical process control, Building and sustaining total quality organizations.
…. PLUS…. The mid-syllabus will be 30%
…. PLUS…. First 150 MCQs from chapters 2 of the book ” MCQs in Biochemistry”. MCQs from the taught concepts and book chapters will also appear in the exam.
Start preparing your presentations and assignments….. Assignment submission is the first class (of Biochem-510) of the second week of next month. The presentations will also be started after mid-term exam.
NO EXCUSE WILL BE ACCEPTED
__________________________________________________________________________________
Meeting ID: 316 824 288 013
Passcode: WNyjeA
Microsoft teams will be used whenever online classes will be held. You must make your first name as your registration number.
2017-ag-9382 Haidar Iftikhar
2017-ag-10077 Ahmad Faraz
BIOCHEM-510 INDUSTRIAL MANAGMEMENT AND QUALITY CONTROL 3(3-0)
Course Learning Outcomes
- Interact with industries for product processing.
- Demonstrate the practical skills and knowledge.
- Learn the marketing skills of biochemical products and processes.
Theory
Introduction to industrial management, Basic functions of management, Forms of business and organizational structure, Introduction to manufacturing, Introduction to industrial marketing, Understanding of financial management, Human resource management practices, Basics of operations and productivity, Purchasing and inventory control, Basics of plant layout, Industrial safety and risk management, Lean production, industrial scheduling, Forecasting methods, Understanding of supply chain dynamics, Industrial operations and leadership, Overview of quality and quality control systems, Comparison between quality control and quality assurance, The ISO 9000 standard for quality management systems, Sector-specific standards, ISO 9001 requirements, ISO 14000 series standards, Failure mode and effect analysis, Total productive maintenance, Managing quality improvement teams and projects, Statistical process control, Building and sustaining total quality organizations.
Suggested Readings:
- Kumar, A. 2015. Industrial Management: An Introduction, Alpha Science Intl Ltd
- Halevi, G. Industrial Management: Control and Profit, Springer Inc. Germany.
- Besterfield, D.H. and C.B. Michna. 2011. Total Quality Management, Revised 3rd Edition. Pearson Education, South Asia.
- Kitaw, D. 2009. Industrial Management and Engineering Economy: an Introduction to Industrial Engineering, AAU Press.
| Biochem-510, BS Biochem, 5TH, M-Winter 2023, Dr. Muhammad Ali; 28-08-2023 | ||||
| Sr. | Ag No. | Student’s Name | Group | Research article for presentation and 1 page summary |
| 1 | 2021-ag-8431 | Eisha Zahid | G1 | CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells |
| 2 | 2021-ag-8441 | Linta Shafique | ||
| 3 | 2021-ag-8452 | Muhammad Haris | ||
| 4 | 2021-ag-8458 | Muhammad Ramzan | ||
| 5 | 2021-ag-8463 | Nimra Shoukat | ||
| 6 | 2021-ag-8466 | Noor-Ul-Ain | G2 | Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies |
| 7 | 2021-ag-8472 | Saliha Nawaz | ||
| 8 | 2021-ag-8484 | Abdul Qadeer | ||
| 9 | 2021-ag-8485 | Aleena Khalid | ||
| 10 | 2021-ag-8486 | Aleeza Tahir | ||
| 11 | 2021-ag-8487 | Ali Raza | G3 | Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy |
| 12 | 2021-ag-8488 | Amna Hamid | ||
| 13 | 2021-ag-8490 | Anooma | ||
| 14 | 2021-ag-8491 | Ansa Sehar | ||
| 15 | 2021-ag-8492 | Areej Fatima Ikram | ||
| 16 | 2021-ag-8493 | Asnan Saleem | G4 | A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes |
| 17 | 2021-ag-8494 | Ayesha Hassan | ||
| 18 | 2021-ag-8495 | Ayesha Tahir | ||
| 19 | 2021-ag-8496 | Esha Batool | ||
| 20 | 2021-ag-8497 | Esha Mujahid | ||
| 21 | 2021-ag-8498 | Fatima Haider | G5 | Small-molecule MHC-II inducers promote immune detection and anti-cancer immunity via editing cancer metabolism |
| 22 | 2021-ag-8499 | Fatima Tahir | ||
| 23 | 2021-ag-8500 | Ghazia Ashraf | ||
| 24 | 2021-ag-8501 | Hadia Akram | ||
| 25 | 2021-ag-8502 | Hafsa Areej | ||
| 26 | 2021-ag-8503 | Iman Fatima | G6 | Glutamine Metabolism Regulates Proliferation and Lineage Allocation in Skeletal Stem Cells |
| 27 | 2021-ag-8504 | Iman Fatima | ||
| 28 | 2021-ag-8505 | Iqra Javed | ||
| 29 | 2021-ag-8507 | Kashaf E Noor | ||
| 30 | 2021-ag-8509 | Khadija Fatima | ||
| 31 | 2021-ag-8510 | Kiran Arshad | G7 | siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer |
| 32 | 2021-ag-8511 | Mahnoor | ||
| 33 | 2021-ag-8512 | Mahnoor Fatima | ||
| 34 | 2021-ag-8513 | Manahil Kashif | ||
| 35 | 2021-ag-8514 | Maryam Naseer | ||
| 36 | 2021-ag-8515 | Minahil | G8 | An in vivo and in vitro assessment of the anti-breast cancer activity of crude extract and fractions from Prunella vulgaris L. |
| 37 | 2021-ag-8517 | M.Ahtesham Muhedeen | ||
| 38 | 2021-ag-8518 | M. Ehtisham Basel | ||
| 39 | 2021-ag-8521 | Muhammad Shahzad | ||
| 40 | 2021-ag-8525 | Muqaddas Raza | ||
| 41 | 2021-ag-8526 | Naila Nawaz | G9 | Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles |
| 42 | 2021-ag-8527 | Namal Rauf | ||
| 43 | 2021-ag-8528 | Nimra Akram | ||
| 44 | 2021-ag-8529 | Noor Fatima | ||
| 45 | 2021-ag-8530 | Noor Fatima | ||
| 46 | 2021-ag-8531 | Noreen Ayesha | G10 | RNF8-mediated regulation of Akt promotes lung cancer cell survival and resistance to DNA damage |
| 47 | 2021-ag-8532 | Rafia Zulfiqar | ||
| 48 | 2021-ag-8533 | Sadaqat Ali | ||
| 49 | 2021-ag-8535 | Toima Riaz | ||
| Biochem-515, BS Biochem, 5TH, E-Winter 2023, Dr. Muhammad Ali; 28-08-2023 | ||||
| Sr. | Ag No. | Student’s Name | Group | Research article for presentation and 1 page summary |
| 1 | 2021-ag-8412 | Abdul Qayyum Ashraf | G1 | A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors |
| 2 | 2021-ag-8413 | Abdullah Saeed | ||
| 3 | 2021-ag-8414 | Ahmad Shahab | ||
| 4 | 2021-ag-8415 | Aiman iftikhar | ||
| 5 | 2021-ag-8416 | Aleesha Rubab | ||
| 6 | 2021-ag-8417 | Ali Haider | ||
| 7 | 2021-ag-8418 | Alina Naz | ||
| 8 | 2021-ag-8419 | Almira Eman | G2 | Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy |
| 9 | 2021-ag-8420 | Aneeza Sattar | ||
| 10 | 2021-ag-8421 | Aqsa Shehzadi | ||
| 11 | 2021-ag-8422 | Areeb Fatima | ||
| 12 | 2021-ag-8423 | Arooj Fatima | ||
| 13 | 2021-ag-8424 | Asma | ||
| 14 | 2021-ag-8425 | Ayesha Nadeem | ||
| 15 | 2021-ag-8426 | Ayesha Noor | G3 | A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors |
| 16 | 2021-ag-8427 | Bushra Bibi | ||
| 17 | 2021-ag-8428 | Chaudhry Abdul wasiq | ||
| 18 | 2021-ag-8429 | Dildar | ||
| 19 | 2021-ag-8430 | Eisha Noor | ||
| 20 | 2021-ag-8431 | Eisha Zahid | ||
| 21 | 2021-ag-8432 | Eman | ||
| 22 | 2021-ag-8433 | Farooq Haider | G4 | Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1 |
| 23 | 2021-ag-8434 | Hafiza Hamna Munawar | ||
| 24 | 2021-ag-8435 | Hafiza khizra Noor | ||
| 25 | 2021-ag-8436 | Hajra Ali | ||
| 26 | 2021-ag-8437 | Hammad Jaffar Raza | ||
| 27 | 2021-ag-8438 | Hira Rafique | ||
| 28 | 2021-ag-8439 | Kiran Shehzadi | ||
| 29 | 2021-ag-8440 | Laraib Mubarik | ||
| 30 | 2021-ag-8441 | Linta Shafique | G5 | Mesoporous Silica Nanoparticles as Drug Delivery Systems for Targeted Inhibition of Notch Signaling in Cancer |
| 31 | 2021-ag-8442 | Maham Shafarash | ||
| 32 | 2021-ag-8443 | Malaika Noor | ||
| 33 | 2021-ag-8444 | Mariam Zia | ||
| 34 | 2021-ag-8445 | Marium Ashfaq | ||
| 35 | 2021-ag-8446 | Mehak Mouazam | ||
| 36 | 2021-ag-8447 | Mehrab Fatima | ||
| 37 | 2021-ag-8448 | Mian Muhammad Farrukh Rashid | G6 | L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity |
| 38 | 2021-ag-8449 | Mina Fatima | ||
| 39 | 2021-ag-8450 | Muhammad Adnan Atta | ||
| 40 | 2021-ag-8451 | Muhammad Arslan Tahir | ||
| 41 | 2021-ag-8452 | Muhammad Haris | ||
| 42 | 2021-ag-8453 | Muhammad Hashim | ||
| 43 | 2021-ag-8454 | Muhammad Hashim | ||
| 44 | 2021-ag-8455 | Muhammad Mukarram | G7 | BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells |
| 45 | 2021-ag-8456 | Muhammad Mustafa | ||
| 46 | 2021-ag-8457 | Muhammad Rafay Ahmad | ||
| 47 | 2021-ag-8458 | Muhammad Ramzan | ||
| 48 | 2021-ag-8459 | Muhammad Umair | ||
| 49 | 2021-ag-8460 | Muhammad Waleed Hashir | ||
| 50 | 2021-ag-8461 | Mujahid Ali | ||
| 51 | 2021-ag-8462 | Nida Aslam | G8 | The topoisomerase inhibitor CPT-11 prevents the growth and metastasis of lung cancer cells in nude mice by inhibiting EGFR/ MAPK signaling pathway |
| 52 | 2021-ag-8463 | Nimra Shoukat | ||
| 53 | 2021-ag-8464 | Noor Fakhar | ||
| 54 | 2021-ag-8465 | Noor Fatima | ||
| 55 | 2021-ag-8466 | Noor-ul-Ain | ||
| 56 | 2021-ag-8467 | Rabeea Rafhan | ||
| 57 | 2021-ag-8468 | Saba Irshad | ||
| 58 | 2021-ag-8469 | Sadaf Javed | G9 | Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model |
| 59 | 2021-ag-8470 | Sadia Altaf | ||
| 60 | 2021-ag-8471 | Saira Zafar | ||
| 61 | 2021-ag-8472 | Saliha Nawaz | ||
| 62 | 2021-ag-8473 | Saman Bashir | ||
| 63 | 2021-ag-8474 | Sana Bushra | ||
| 64 | 2021-ag-8475 | Syeda Sajjal Bukhari | ||
| 65 | 2021-ag-8476 | Sehar Anees | ||
| 66 | 2021-ag-8477 | Sheraz Nazir | G10 | ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression |
| 67 | 2021-ag-8478 | Sidra-TUL-Muntaha | ||
| 68 | 2021-ag-8479 | Taiba Amin | ||
| 69 | 2021-ag-8480 | Tanzeela Imran | ||
| 70 | 2021-ag-8481 | Tuba Ahmad | ||
| 71 | 2021-ag-8482 | UM-E-LAILA | ||
| 72 | 2021-ag-8483 | Usman Ghani | ||
Add your first comment to this post
Comments are closed.